Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review

BACKGROUND: The introduction of immunotherapy in the treatment of non-small cell lung cancer (NSCLC) has resulted in a radical change in patients’ treatment responses and survival rates. The increased percentage of long survivors, improved toxicity profiles compared to chemotherapy, and the possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivares-Hernández, Alejandro, González del Portillo, Elísabet, Tamayo-Velasco, Álvaro, Figuero-Pérez, Luis, Zhilina-Zhilina, Svetlana, Fonseca-Sánchez, Emilio, Miramontes-González, José Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477621/
https://www.ncbi.nlm.nih.gov/pubmed/37675322
http://dx.doi.org/10.21037/atm-22-4218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477621/
https://www.ncbi.nlm.nih.gov/pubmed/37675322
http://dx.doi.org/10.21037/atm-22-4218

Ejemplares similares